AstraZeneca
No mentions found
This entity hasn't been tracked yet, or Iris is still building its knowledge base.
Related Articles from SNS
AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success
AstraZeneca CEO Pascal Soriot said artificial intelligence is helping drugmakers develop medicines faster and make smarter decisions throughout the research process. "The value of AI in our industry is productivity improvement," Soriot said on CNBC's "Mad Money" on Friday. "In the way you design a new medicine, a new drug, you can actually do it faster, do it smarter."
AstraZeneca advances weight-loss pill to take aim at obesity leaders
Pill from drugmaker would put it into competition with market leaders Novo Nordisk and Eli Lilly
AstraZeneca chief warns group could withhold new drugs in Europe
Sir Pascal Soriot says countries will have to spend more on innovative medicines following US trade deal
Life-saving breast cancer and endometriosis drug to be discontinued
AstraZeneca pulls critical breast cancer and endometriosis drug Zoladex from shelves Thu 4 Jun 2026 at 4:49am In short: AstraZeneca has announced it will pull a critical breast cancer and endometriosis drug from Australian shelves from November. Patients have labelled the decision "cruel" and say they have been blindsided. AstraZeneca says it will provide free access to the drug for six months for those without alternative treatment pathways.
Breast cancer and endometriosis drug Zoladex is being pulled from Australia. How will women be affected?
The vital medicine, made by AstraZeneca, will not be available from November, possibly leaving thousands of women without treatmentGet our breaking news email, free app or daily news podcastThousands of women could be left without vital breast cancer and endometriosis medicine when AstraZeneca removes its treatment from the Pharmaceutical Benefits Scheme (PBS) and the private market, experts warn. Zoladex will no longer be available in Australia from November, as the ABC first reported, but...
UK scientists developing vaccine for new Ebola outbreak
New jab being developed by the Oxford Vaccine Group uses same technology behind the AstraZeneca Covid-19 vaccine
Mutation-dependent responses to sleep and exercise in clonal haematopoiesis
Abstract Clonal haematopoiesis (CH) activates inflammation and increases the risk of atherosclerosis1,2. Whether lifestyle alters CH clone expansion or the phenotypic programming of CH mutant cells, thereby affecting atherosclerosis, is unknown. Here, in humans and mice and across mutations in Jak2, Tet2, Trp53 and Dnmt3a, we demonstrate mutation-dependent responses to sleep and exercise in CH and show that mutant cells are uniquely sensitive to lifestyle.
Platner’s anti-corporate crusade hits awkward snag as receipts tell another story
Maine Democratic Senate candidate Graham Platner built a national reputation as an anti-corporate crusader while cashing checks written by lobbyists and executives representing those same corporations, campaign finance documents show. Platner has made criticism of big tech, the pharmaceutical industry, large banks and defense contractors a cornerstone of his campaign to unseat incumbent GOP Sen. Susan Collins. Federal Election Commission and Lobbying Disclosure Act records reviewed by Fox...
UK-China ‘ice age’ thaws: Why the West needs Beijing
UK-China ‘ice age’ thaws: Why the West needs Beijing British Foreign Secretary Yvette Cooper hails ‘candour and respect’ in new ties with Beijing, despite differences. Eight years after a British prime minister and foreign secretary made back-to-back visits to China, the Keir Starmer government is once again trying to reset relations with Beijing after a long period of what Starmer had in January described as an “ice age” in relations. Prime Minister Starmer went to Beijing in January, and...